Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Mycotopia Therapies Inc TPIA

Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (OTCPK:TPIA)

Fundamentals Snapshot (OTCPK:TPIA)

Current News (OTCPK:TPIA)

Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ

GlobeNewswire May 23, 2022

Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction

PR Newswire May 20, 2022

Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction

GlobeNewswire May 19, 2022

Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments

GlobeNewswire May 9, 2022

Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market

GlobeNewswire May 2, 2022

Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products

GlobeNewswire March 21, 2022

Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.

GlobeNewswire March 17, 2022

Ehave Issues Shareholder Letter and Provides Corporate Update

GlobeNewswire January 31, 2022

Mycotopia Therapies Announces Ei.Ventures Acquires 12x12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022

GlobeNewswire January 6, 2022

Opinion & Analysis (OTCPK:TPIA)

No current opinion is available.

Bullboard Posts (OTCPK:TPIA)

Mycotopia Therapies Announces Plan to Develop Psychedelic

Mycotopia Therapies and Agile Pharmaceutical Solutions plan to conduct oversight and development of the tablet in Jamaica and explore...
AveragePenny - November 17, 2021

Mycotopia Therapies Appoints Experienced Mental Health

Senator Dr. Longmore received her M.B.B.S and Doctor of Medicine in Psychiatry, from the University Hospital of the West Indies and has...
AveragePenny - November 10, 2021

Mycotopia Therapies Issues CEO Letter to Stockholders

To My Fellow Stockholders, Over the course of 2021, Mycotopia Therapies has made significant progress in advancing our strategic plan...
AveragePenny - November 4, 2021